AG
PBH icon

Aperio Group’s Prestige Consumer Healthcare PBH Stock Holding History

Aperio Group’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.78M Sell
51,065
-6,779
-12% -$241K 0.01% 1295
2020
Q3 		$2.11M Sell
57,844
-2,207
-4% -$82.1K 0.01% 1093
2020
Q2 		$2.26M Buy
60,051
+3,955
+7% +$158K 0.01% 1055
2020
Q1 		$2.06M Buy
56,096
+7,444
+15% +$289K 0.01% 1006
2019
Q4 		$1.97M Sell
48,652
-2,888
-6% -$108K 0.01% 1095
2019
Q3 		$1.79M Buy
51,540
+1,584
+3% +$52.2K 0.01% 1108
2019
Q2 		$1.58M Buy
49,956
+7,258
+17% +$216K 0.01% 1178
2019
Q1 		$1.28M Sell
42,698
-46,190
-52% -$1.32M 0.01% 1245
2018
Q4 		$2.75M Sell
88,888
-19,860
-18% -$725K 0.01% 860
2018
Q3 		$4.12M Sell
108,748
-4,497
-4% -$170K 0.02% 751
2018
Q2 		$4.35M Buy
113,245
+77,478
+217% +$2.61M 0.02% 720
2018
Q1 		$1.21M Buy
35,767
+5,657
+19% +$217K 0.01% 1224
2017
Q4 		$1.34M Buy
30,110
+2,094
+7% +$95.4K 0.01% 1159
2017
Q3 		$1.4M Buy
28,016
+761
+3% +$38.9K 0.01% 1098
2017
Q2 		$1.44M Sell
27,255
-45
-0.2% -$2.41K 0.01% 1056
2017
Q1 		$1.52M Buy
27,300
+11,191
+69% +$617K 0.01% 972
2016
Q4 		$839K Buy
16,109
+2,023
+14% +$97.6K 0.01% 1209
2016
Q3 		$680K Sell
14,086
-1,091
-7% -$55.2K ﹤0.01% 1295
2016
Q2 		$841K Buy
15,177
+2,420
+19% +$133K 0.01% 1150
2016
Q1 		$681K Buy
12,757
+2,129
+20% +$105K 0.01% 1220
2015
Q4 		$547K Buy
10,628
+2,562
+32% +$127K 0.01% 1292
2015
Q3 		$364K Buy
8,066
+804
+11% +$38K ﹤0.01% 1464
2015
Q2 		$336K Buy
7,262
+295
+4% +$12.9K ﹤0.01% 1562
2015
Q1 		$299K Buy
6,967
+963
+16% +$36.7K ﹤0.01% 1568
2014
Q4 		$208K Buy
+6,004
New +$199K ﹤0.01% 1721

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Aperio Group's PBH Position: Q4 2020 in Review

Aperio Group reduced its Prestige Consumer Healthcare (PBH) stake by 12% in Q4 2020, selling an estimated $241K and leaving 51,065 shares worth $1.78M. The position accounts for 0.01% of the portfolio, ranked #1295.

Aperio Group first reported a position in PBH in Q4 2014 and has held it in 25 quarters since. The position peaked at $4.35M in Q2 2018. 237 funds tracked by Wall St. Rank hold PBH as of Q4 2020.

  • Aperio Group held 51,065 shares of Prestige Consumer Healthcare worth $1.78M as of Q4 2020.
  • Aperio Group sold 6,779 Prestige Consumer Healthcare shares in Q4 2020, an estimated $241K.
  • Prestige Consumer Healthcare made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1295 holding.
  • Aperio Group first reported a position in Prestige Consumer Healthcare in Q4 2014 and has held it in 25 quarters since.
  • Aperio Group's Prestige Consumer Healthcare position peaked at $4.35M in Q2 2018.
  • 237 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.